HomeCYTO • CVE
add
Cytophage Technologies Ltd
Previous close
$0.24
Day range
$0.23 - $0.24
Year range
$0.13 - $0.40
Market cap
13.89M CAD
Avg Volume
77.32K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.12M | -12.06% |
Net income | -1.13M | 9.39% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.00M | 8.71% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.24M | -66.23% |
Total assets | 4.10M | -43.89% |
Total liabilities | 1.97M | -3.84% |
Total equity | 2.13M | — |
Shares outstanding | 61.69M | — |
Price to book | 7.83 | — |
Return on assets | -70.93% | — |
Return on capital | -81.94% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.13M | 9.39% |
Cash from operations | -906.47K | 12.73% |
Cash from investing | -2.00 | 100.00% |
Cash from financing | 1.42M | 1,581.42% |
Net change in cash | 510.06K | 126.66% |
Free cash flow | -512.54K | 62.71% |
